Search icon

UNIVERSITY OF LOUISVILLE

Company claim

Is this your business?

Get access!

Company Details

Name: UNIVERSITY OF LOUISVILLE
Legal type: Kentucky Corporation
Status: Active
Standing: Good
Profit or Non-Profit: Non-profit
File Date: 07 Feb 1846 (179 years ago)
Organization Date: 07 Feb 1846 (179 years ago)
Last Annual Report: 14 Mar 2025 (4 months ago)
Organization Number: 0052977
Industry: Educational Services
Number of Employees: Large (100+)
ZIP code: 40292
City: Louisville
Primary County: Jefferson County
Principal Office: OFFICE OF UNIVERSITY COUNSEL, UNIVERSITY OF LOUISVILLE, LOUISVILLE, KY 40292
Place of Formation: KENTUCKY

Incorporator

Name Role
JOHN W. BARR Incorporator
HELEN BRUCE Incorporator
ARTHUR B. ALLEN Incorporator
WM. S. SPEED Incorporator
HARRY A. DAVIDSON Incorporator

Registered Agent

Name Role
ANGELA CURRY Registered Agent

Director

Name Role
Alfonso Cornish Director
Diane Porter Director
Jerry Abramson Director
GEO. W. WEISSINGER Director
Larry Hayes Director
Allie Rose Phillips Director
Chris Dischinger Director
Eugene Mueller Director
GARNETT DUNCAN Director
SAMUEL S. NICHOLAS Director

Treasurer

Name Role
Brian Lavin Treasurer

Secretary

Name Role
Sherrill Zimmerman Secretary

Officer

Name Role
Diane Medley Officer
Larry Benz Officer

President

Name Role
Kim Schatzel President

Unique Entity ID

Unique Entity ID:
YCMNFLK5Z725
CAGE Code:
9S244
UEI Expiration Date:
2025-08-01

Business Information

Division Name:
OFFICE OF THE BURSAR
Activation Date:
2024-08-01
Initial Registration Date:
2001-12-10

Commercial and government entity program

CAGE number:
9S244
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2025-07-08
CAGE Expiration:
2030-07-08
SAM Expiration:
2026-07-03

Contact Information

POC:
ELIZABETH A. THOMASON

National Provider Identifier

NPI Number:
1336644350

Authorized Person:

Name:
WHITNEY NASH
Role:
DIRECTOR
Phone:

Taxonomy:

Selected Taxonomy:
363L00000X - Nurse Practitioner
Is Primary:
Yes

Contacts:

Fax:
5028520704

Former Company Names

Name Action
THE PRESIDENTS & TRUSTEE'S OF THE UNIVERSITY OF LOUISVILLE Old Name

Assumed Names

Name Status Expiration Date
UOFL CARE PARTNERS Inactive 2022-10-23

Filings

Name File Date
Annual Report 2025-03-14
Annual Report 2024-03-06
Annual Report 2023-03-17
Annual Report 2022-03-21
Registered Agent name/address change 2021-04-05

USAspending Awards / Contracts

Procurement Instrument Identifier:
36C24925N0346
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
2137061.79
Base And Exercised Options Value:
2137061.79
Base And All Options Value:
2137061.79
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2025-04-01
Description:
BASE ORDERING PERIOD FOR RADIOLOGY WRVU SERVICES
Naics Code:
611310: COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS
Product Or Service Code:
Q522: MEDICAL- RADIOLOGY
Procurement Instrument Identifier:
36C24925D0051
Award Or Idv Flag:
IDV
Action Obligation:
0.00
Base And All Options Value:
23586878.78
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2025-04-01
Description:
RADIOLOGY WRVU SERVICES
Naics Code:
611310: COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS
Product Or Service Code:
Q522: MEDICAL- RADIOLOGY
Procurement Instrument Identifier:
36C24925N0264
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
360115.84
Base And Exercised Options Value:
360115.84
Base And All Options Value:
360115.84
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2025-01-01
Description:
THORACIC SURGERY SERVICES POP 1/1/2025 THROUGH 12/31/2025
Naics Code:
611310: COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS
Product Or Service Code:
Q524: CARDIOTHORACIC SURGERY

USAspending Awards / Financial Assistance

Date:
2025-05-30
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
TARGETING DISEASE SPECIFIC TN ANTIGEN IN PANCREATIC CANCER - ABSTRACT / PROJECT SUMMARY PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS A HIGHLY LETHAL DISEASE. OVER 80% OF PDAC PATIENTS HAVE LOCALLY ADVANCED OR HIGHLY METASTATIC DISEASE AT DIAGNOSIS. FOLFIRINOX AND GEMCITABINE/NAB-PACLITAXEL ARE CURRENTLY USED AS THE STANDARD OF CARE FOR ADVANCED PDAC PATIENTS, BUT RESPONSES ARE INCOMPLETE. THUS, THERE IS AN URGENT AND UNMET NEED TO DEVELOP NOVEL TARGETED THERAPEUTIC STRATEGIES AGAINST PDAC. MORE THAN 80% OF PDACS EXPRESS SURFACE GLYCOPROTEINS CARRYING THE CANCER-ASSOCIATED CARBOHYDRATE ANTIGENS TN AND SIALYL TN (STN), WHOSE EXPRESSION DOES NOT NORMALLY OCCUR IN THE PANCREAS OR OTHER TISSUE AND IS ASSOCIATED WITH POOR PROGNOSIS AND REDUCED OVERALL SURVIVAL OF PDAC PATIENTS. IN ADDITION TO SERVING AS A PROGNOSTIC BIOMARKER, WE DISCOVERED THAT TN/STN ANTIGENS ON GLYCOPROTEINS ALTER BIOLOGICAL ACTIVITY REGARDING GROWTH FACTORS AND CYTOKINES. OUR PRELIMINARY DATA DEMONSTRATE THAT OVEREXPRESSION OF TN/STN ANTIGENS ENHANCES PDAC DISEASE PROGRESSION, AND METASTASIS AND REDUCES THE OVERALL SURVIVAL OF TUMOR-BEARING ANIMALS. ALSO, INDUCED EXPRESSION OF TN/STN ANTIGENS ON GLYCOPROTEIN RECEPTORS AND LIGANDS RESULTS IN THE ACTIVATION OF ONCOGENIC SIGNALING CASCADES THROUGH THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR/ERBB1) AND ITS DOWNSTREAM PI3K/AKT SIGNALING CASCADES THAT INCREASE THE MALIGNANT POTENTIAL OF PDAC CELLS. TREATMENT OF TN+ CANCER CELLS WITH A NEWLY DEVELOPED AFUCOSYLATED MONOCLONAL ANTIBODY (MAB) ANTI-TN (AREMAB6), INDUCES COMPLEMENT-DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC). IN ADDITION, TREATMENT OF TN+ TUMOR-BEARING ANIMALS WITH AREMAB6 INHIBITS IN VIVO TUMOR GROWTH AND METASTASIS VIA NATURAL KILLER (NK) CELL-MEDIATED ADCC. WE HYPOTHESIZE THAT THE CANCER-SPECIFIC EXPRESSION OF THE TN ANTIGEN PLAYS A MAJOR ROLE IN PDAC GROWTH, METASTASIS, AND SURVIVAL. THEREFORE, WE PROPOSE (AIM 1) TO DETERMINE THE MECHANISMS BY WHICH TN ANTIGEN ENHANCES PDAC TUMOR PROGRESSION AND IDENTIFY TN-EXPRESSING GLYCOPROTEINS BY GLYCOPROTEOMICS IN THE MOUSE MODEL AND CLINICAL SPECIMENS USING A UNIQUE SET OF SAMPLES OBTAINED FROM RAPID AUTOPSIES OF PATIENTS THAT DIED OF PDAC. (AIM 2) WE WILL VALIDATE THE ROLES OF NK CELL IN AREMAB6-MEDIATED ADCC AND EVALUATE THE AREMAB6 ANTIBODY-INDUCED ANTITUMOR IMMUNE RESPONSE IN GENETICALLY ENGINEERED SPONTANEOUS IMMUNOCOMPETENT MOUSE MODELS OF PDAC THAT ARE FURTHER ENGINEERED TO EXPRESS TN ANTIGEN ON GLYCOPROTEINS (KPC-COSMCKO). (AIM 3) WE WILL DETERMINE THE “OFF-TUMOR” TOXICITY OF AREMAB6 AND EVALUATE THE THERAPEUTIC EFFICACY OF AREMAB6 PLUS GEMCITABINE/NAB- PACLITAXEL AGAINST THE TN ANTIGEN-EXPRESSING IMMUNOCOMPETENT SPONTANEOUS KPC AND KPC-COSMCKO TUMOR MODELS. THESE MODELS CLOSELY RECAPITULATE THE TUMOR BIOLOGY OF HUMAN PDAC TUMORS AND WILL AID IN TRANSLATING THESE PRECLINICAL FINDINGS TO HUMAN CANCER. TOGETHER, THESE STUDIES WILL LEAD TO A NEW UNDERSTANDING OF FACTORS CONTRIBUTING TO PANCREATIC TUMOR PROGRESSION AND METASTASIS. ALSO, THE STUDIES IN THIS PROPOSAL HAVE THE POTENTIAL TO DEVELOP AREMAB6-BASED TARGETED THERAPEUTIC STRATEGY AGAINST METASTATIC PDAC.
Obligated Amount:
551540.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-05-21
Awarding Agency Name:
National Science Foundation
Transaction Description:
CDS&E/COLLABORATIVE RESEARCH: PHYSICS-INFORMED MACHINE LEARNING FOR TAILORING THE MULTIDIRECTIONAL MECHANICAL PROPERTIES OF COMPOSITE MATERIALS -THIS COMPUTATIONAL AND DATA-ENABLED SCIENCE AND ENGINEERING (CDS&E) COLLABORATIVE RESEARCH PROJECT WILL CONTRIBUTE TO THE PROGRESS OF SCIENCE AND THE ADVANCEMENT OF NATIONAL PROSPERITY BY DEVELOPING A FRAMEWORK FOR THE INVERSE DESIGN AND FABRICATION OF MULTIPHASE COMPOSITE MATERIALS WITH TAILORED MECHANICAL PROPERTIES. DESPITE RECENT ADVANCES IN THE DEPLOYMENT OF MACHINE LEARNING TECHNIQUES TO MATERIALS SCIENCE, THE CREATION OF MATERIALS WITH DESIRED MECHANICAL PROPERTIES IN MULTIPLE LOADING DIRECTIONS REMAINS A SIGNIFICANT CHALLENGE. THIS RESEARCH PLANS A NEW DATA-DRIVEN FRAMEWORK TO UNDERSTAND THE RELATIONSHIP BETWEEN MATERIAL ARCHITECTURE AND MECHANICAL BEHAVIOR, FACILITATING THE DESIGN OF NONLINEAR MATERIALS FOR A WIDE RANGE OF APPLICATIONS SUCH AS LIGHTWEIGHT STRUCTURES, SHOCK ABSORBERS, AND AEROSPACE COMPONENTS. THIS RESEARCH WILL BE INTEGRATED WITH EDUCATIONAL AND OUTREACH PROGRAMS AIMED AT ATTRACTING UNDERREPRESENTED GROUPS TO ENGINEERING AND IMPROVING UNDERGRADUATE AND GRADUATE LEARNING IN DATA-DRIVEN SCIENCE AND ENGINEERING. HIGH SCHOOL STUDENTS AND THE PUBLIC WILL BE INTRODUCED TO DATA-DRIVEN MATERIAL DESIGN AND APPLICATIONS IN COLLABORATION WITH A LOCAL MUSEUM AND SCIENCE CENTER. THIS COLLABORATIVE RESEARCH WILL CREATE AND TEST A NEW PHYSICS-INFORMED DEEP LEARNING (PIDL) FRAMEWORK TO TAILOR THE MULTIDIRECTIONAL OR MULTI-OBJECTIVE MECHANICAL PROPERTIES OF EXOTIC COMPOSITE MATERIALS. IT WILL UTILIZE THE PRINCIPLES OF PIDL TO BUILD A DATA-EFFICIENT AND PHYSICALLY INTERPRETABLE SURROGATE MODEL OF STRUCTURE-PROPERTY RELATIONSHIPS FOR MULTIPHASE COMPOSITE MATERIALS. THIS RESEARCH WILL FORMULATE CONSTITUTIVE EQUATIONS FOR CONSTITUENTS IN VOXEL-BASED COMPOSITE MATERIALS AND INCORPORATE THEM INTO A FORWARD PHYSICS-INFORMED CONVOLUTIONAL NEURAL NETWORK MODEL. A NOVEL MULTI-OBJECTIVE INVERSE PHYSICS-INFORMED CONDITIONAL DIFFUSION MODEL WILL BE DEVELOPED TO REVEAL THE PROPERTY-STRUCTURE CORRELATION BETWEEN A MULTIPHASE COMPOSITE MATERIAL?S BULK MECHANICAL PROPERTIES AND ITS ARCHITECTURE, COMBINING MACROSCOPIC AND MICROSCOPIC DATA TO ENHANCE MODEL ACCURACY AND ROBUSTNESS. FINALLY, THE DESIGNED MATERIALS WILL BE ADDITIVELY MANUFACTURED AND TESTED, WITH VALIDATION THROUGH ADVANCED ADDITIVE MANUFACTURING, X-RAY IMAGING, AND MULTIAXIAL TESTING. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.
Obligated Amount:
0.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-05-27
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
REAL-TIME MONITORING OF RELAPSE IN EATING DISORDERS - PROJECT SUMMARY/ABSTRACT EATING DISORDERS (EDS) ARE SEVERE MENTAL ILLNESSES WITH HIGH MORTALITY,1 FEW EFFECTIVE TREATMENTS,2–4 AND HIGH RELAPSE RATES.5 CURRENT EVIDENCE-BASED TREATMENTS FOR EDS OFTEN RESULT IN ONLY 50% OF INDIVIDUALS REACHING FULL REMISSION OF THEIR SYMPTOMS.4 FURTHER, EVEN AMONG THOSE WHO DO RECOVER, MANY RELAPSE. UP TO 50% OF THOSE WHO RECOVER EXPERIENCE A RELAPSE AFTER TREATMENT, ABOUT 25% OF INDIVIDUALS GO ON TO EXPERIENCE A SEVERE AND PERSISTENT COURSE OF ILLNESS.5–13 DESPITE THESE HIGH RATES OF RELAPSE, THE PAST DECADES OF RESEARCH HAVE CULMINATED IN VERY LITTLE IMPROVEMENT TO PREVENT RELAPSE WITHIN THE EDS. TO DATE, WE STILL KNOW VERY LITTLE ABOUT WHY RELAPSE OCCURS; IN PART, BECAUSE ED RELAPSE HAS BEEN STUDIED PRIMARILY AS AN OUTCOME (I.E., RELAPSED OR NOT) RATHER THAN A DYNAMIC PROCESS CAN BE INTERVENED UPON.9,14 RECONCEPTUALIZING AND STUDYING ED RELAPSE AS A DYNAMIC PROCESS WILL AID THE IDENTIFICATION OF MECHANISMS OF RELAPSE AND INFORM THE DEVELOPMENT AND REFINEMENT OF INTERVENTIONS AND RELAPSE PREVENTION EFFORTS. A WELL-ESTABLISHED MODEL OF RELAPSE IN SUBSTANCE USE DISORDERS (I.E., THE COGNITIVE BEHAVIORAL RELAPSE MODEL; CBRM)15 CAN INFORM THE INITIAL FORMATION OF A SIMILAR MODEL IN EDS. WITH RESEARCH DESIGN INFORMED BY THE CBRM, THE PROPOSED STUDY WILL USE MICRO-LONGITUDINAL (I.E., ECOLOGICAL MOMENTARY ASSESSMENT) AND LONGITUDINAL (I.E., 3-MONTH FOLLOW-UP) METHODS TO CAPTURE LAPSES AND RELAPSE AMONG THOSE WITH EDS. THE USE OF THEORY-DRIVEN, FINE-GRAINED ASSESSMENT WILL MOVE THE FIELD TOWARD THE ELUCIDATION OF DISTAL AND PROXIMAL MECHANISMS OF RELAPSE AS IT UNFOLDS IN REAL-TIME. FIRST, WE WILL CAPTURE THE PRESENCE AND DYNAMICS OF LAPSES (I.E., MOMENTARY ENGAGEMENT IN ED BEHAVIORS), AND WHETHER FEATURES OF LAPSES (E.G., FREQUENCY, TIME BETWEEN LAPSES) PREDICT EVENTUAL RELAPSE (AIM 1). THE CBRM SPECIFIES THAT BOTH TONIC PROCESSES (I.E., STABLE, CHRONIC FACTORS) AND PHASIC RESPONSES (I.E., IMMEDIATE PRECIPITANTS) INCREASE THE RISK FOR RELAPSE. AS SUCH, WE WILL TEST THE ASSOCIATIONS BETWEEN TONIC PROCESSES AND THE PROPENSITY FOR LAPSING (I.E., HIGHER URGE VALENCE AND STABILITY AND LOWER URGE VARIABILITY; AIM 2). ADDITIONALLY, WE WILL USE GENERALIZED ESTIMATING EQUATION MODELS TO EXAMINE WHETHER EACH PROPOSED PHASIC RESPONSE (E.G., AFFECT, EMOTION REGULATION SKILL USE) PREDICTS A LAPSE AT THE NEXT SURVEY (AIM 3). LASTLY, THE CBRM POSITS THAT “HIGH-RISK” SITUATIONS INCREASE THE LIKELIHOOD OF AN INDIVIDUAL LAPSING. THIS STUDY WILL AID IN THE INITIAL IDENTIFICATION OF SAID HIGH-RISK SITUATIONS IN EDS BY USING MIXED-METHOD (I.E., QUALITATIVE AND QUANTITATIVE) ANALYSES TO EXPLORE CONTEXTUAL FACTORS CONTRIBUTING TO INDIVIDUALS’ REPORTED LAPSES (EXPLORATORY AIM 4). OVERALL, THE PROPOSED PROJECT WILL IMPLEMENT ADVANCED STATISTICS AND MICRO- AND MACRO-LONGITUDINAL DESIGN TO PROVIDE AN INITIAL MECHANISTIC UNDERSTANDING OF RELAPSE AS IT OCCURS IN THE EDS. FINDINGS FROM THIS STUDY WILL INFORM THE REFINEMENT OF RELAPSE PREVENTION INTERVENTIONS AND JUST-IN-TIME ADAPTIVE INTERVENTIONS, AND ULTIMATELY, PROMOTE LASTING, LONG-TERM RECOVERY FOR THOSE WITH THIS IMPAIRING AND PERSISTENT DISORDER.
Obligated Amount:
45516.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-05-23
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DIETARY FRUCTOSE AND NASH/HCC PROGRESSION - PROJECT SUMMARY “DIETARY FRUCTOSE AND NASH/HCC PROGRESSION” NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)/NONALCOHOLIC STEATOHEPATITIS (NASH) IS EMERGING AS A LEADING RISK FACTOR DRIVING THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC). DIETARY FRUCTOSE IS A MAJOR RISK FACTOR FOR NAFLD AND SUBSEQUENT HCC PROGRESSION. FRUCTOSE IS PRIMARILY METABOLIZED BY KETOHEXOKINASE (KHK) AND KHK- DEFICIENT MICE OR PHARMACOLOGIC INHIBITION IS PROTECTIVE AGAINST NAFLD BUT THE UNDERLYING MECHANISMS RESPONSIBLE ARE LARGELY UNEXPLORED. WE RECENTLY DESIGNED STUDIES TO INVESTIGATE WHETHER LOSS OR INHIBITION OF KHK IMPACTS HIF-Α PROTEIN STABILIZATION BY CROSSING HIF STABILIZATION REPORTER (ODD-LUC) MICE WITH KHK-/- MICE DISCOVERED THAT INTESTINAL HIF-STABILIZATION (AS MEASURED BY LUCIFERASE ACTIVITY) IS SIGNIFICANTLY AND CONSISTENTLY REDUCED BY KHK-DEFICIENCY. INTERESTINGLY, REDUCED HIF-Α STABILITY IN KHK-/- MICE IS FULLY RESCUED BY THE SMALL MOLECULE INHIBITOR OF PYRUVATE KINASE M2 (PKM2) SUGGESTING THAT FRUCTOSE/KHK-DEPENDENT HIF-Α STABILIZATION MAY BE MEDIATED BY THE PKM2 INHIBITORY METABOLITE, F1P. CONSISTENT WITH THE REDUCED HIF-Α STABILIZATION OBSERVED IN KHK-DEFICIENT MICE, INTESTINAL EXPRESSION OF THE HIF-2Α-INDUCED IRON TRANSPORTER, DMT1, IS REDUCED IN KHK-/- MICE CONSISTENT WITH OUR OBSERVATIONS THAT KHK-DEFICIENT MICE EXHIBIT SPONTANEOUS SYSTEMIC IRON DEFICIENCY. BECAUSE PLASMA IRON IS ESSENTIAL FOR MAXIMAL NEUTROPOIESIS COUPLED WITH THE FACT THAT KHK-DEFICIENCY ALSO RESULTS IN MARKEDLY REDUCED NEUTROPHIL NUMBERS AND PERCENTAGES, OUR OVERARCHING HYPOTHESIS IS THAT FRUCTOSE FACILITATES INCREASED INTESTINAL IRON ABSORPTION VIA A KHK/F1P/HIF-2Α AXIS, LEADING TO PRO-INFLAMMATORY NEUTROPOIESIS THAT, IN TURN, CONTRIBUTES TO THE DEVELOPMENT OF HCC. WE WILL TEST THIS HYPOTHESIS USING THE FOLLOWING TWO SPECIFIC AIMS: AIM 1. DETERMINE WHETHER DIETARY FRUCTOSE PROMOTES INTESTINAL IRON ABSORPTION IN A KHK, F1P AND HIF-2Α-DEPENDENT MANNER. AIM 2. DETERMINE WHETHER DIETARY FRUCTOSE PROMOTES SYSTEMIC INFLAMMATION LEADING TO PRO-TUMORIGENIC LIVER MICROENVIRONMENTS DUE TO INCREASED IRON-DEPENDENT NEUTROPOIESIS.
Obligated Amount:
402400.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2025-05-16
Awarding Agency Name:
Department of Energy
Transaction Description:
CLEAN CITIES COALITION NETWORK, OUTREACH, EDUCATION, AND PERFORMANCE TRACKING PROGRAM CLEAN CITIES COALITIONS WORK COOPERATIVELY WITH THE DEPARTMENT OF ENERGY'S VEHICLE TECHNOLOGIES OFFICE TO FOSTER THE NATION'S ECONOMIC, ENVIRONMENTAL, AND ENERGY SECURITY BY ACTING LOCALLY TO ADVANCE AFFORDABLE, DOMESTIC TRANSPORTATION FUELS, ENERGY EFFICIENT MOBILITY SYSTEMS, AND OTHER FUEL-SAVING TECHNOLOGIES AND PRACTICES. THE OBJECTIVE OF THIS PROJECT IS FOR THE CLEAN CITIES COALITION TO PROVIDE TECHNICAL ASSISTANCE AND OUTREACH WITHIN THE COALITION’S TERRITORY, PARTICIPATE IN PROGRAM MEETINGS, AND TO TRACK AND REPORT CRITICAL PROGRAM AND PERFORMANCE METRICS.
Obligated Amount:
110000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks

Serial Number:
98423070
Mark:
BROWN CANCER CENTER
Status:
Suspension check completed. Application remains suspended.
Mark Type:
Service Mark
Application Filing Date:
2024-02-27
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
BROWN CANCER CENTER

Goods And Services

For:
Medical research; Providing medical and scientific research information in the field of clinical trials; Scientific study and research in the field(s) of cancer
First Use:
1983-01-19
International Classes:
042 - Primary Class
Class Status:
ACTIVE
For:
Healthcare; Cancer screening services; Health care services for treating cancer; Hospital services; Medical imaging services; Medical testing services relating to the diagnosis and treatment of disease; Providing cancer screening services; Providing healthcare information; Providing information in t...
First Use:
1983-01-19
International Classes:
044 - Primary Class
Class Status:
ACTIVE
Serial Number:
97035480
Mark:
THE ALLEY
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Service Mark
Application Filing Date:
2021-09-20
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
THE ALLEY

Goods And Services

For:
Providing general purpose facilities for tailgating
First Use:
2021-09-11
International Classes:
043 - Primary Class
Class Status:
ACTIVE
Serial Number:
90836353
Mark:
FRANCHISEU
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2021-07-19
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
FRANCHISEU

Goods And Services

For:
Educational services, namely, providing online instruction in the field of franchising; Educational services, namely, providing podcasts and on-line information in the fields of franchising; Educational and entertainment services, namely, a continuing program about franchising accessible by means of...
International Classes:
041 - Primary Class
Class Status:
ACTIVE
Serial Number:
90817347
Mark:
LOUISVILLE
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2021-07-08
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
LOUISVILLE

Goods And Services

For:
Footwear; Headwear; Hoodies; Jackets; Jerseys; Shirts; Shorts; Socks; Sweat pants; Sweat shirts
First Use:
2050-01-19
International Classes:
025 - Primary Class
Class Status:
ACTIVE
For:
Entertainment in the nature of competitions in the field of intercollegiate sports; Education services in the nature of courses at the university level
First Use:
2046-01-18
International Classes:
041 - Primary Class
Class Status:
ACTIVE
Serial Number:
90354717
Mark:
A HEALTHIER U
Status:
Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Service Mark
Application Filing Date:
2020-12-02
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
A HEALTHIER U

Goods And Services

For:
Business administration of programs intended to lower health care costs and increase business productivity through employee health, wellness, and nutritional changes
International Classes:
035 - Primary Class
Class Status:
ACTIVE
For:
Counseling services in the fields of health, nutrition and lifestyle wellness
International Classes:
044 - Primary Class
Class Status:
ACTIVE

OSHA's Inspections within Industry

Inspection Summary

Date:
2015-03-31
Type:
Complaint
Address:
2211 S BROOK STREET, LOUISVILLE, KY, 40292
Safety Health:
Health
Scope:
Partial

Inspection Summary

Date:
2015-01-22
Type:
Complaint
Address:
2301 S THIRD STREET, LOUISVILLE, KY, 40292
Safety Health:
Safety
Scope:
Partial

Inspection Summary

Date:
2001-06-22
Type:
Complaint
Address:
1800 ARTHUR STREET, LOUISVILLE, KY, 40208
Safety Health:
Health
Scope:
Partial

Inspection Summary

Date:
2000-06-13
Type:
Complaint
Address:
1980 ARTHUR STREET, LOUISVILLE, KY, 40208
Safety Health:
Health
Scope:
Partial

Inspection Summary

Date:
1999-12-13
Type:
Complaint
Address:
2211 S BROOK STREET, LOUISVILLE, KY, 40208
Safety Health:
Health
Scope:
Partial

Court Cases

Court Case Summary

Filing Date:
2024-11-13
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Civil Rights Employment

Parties

Party Name:
WOLEK
Party Role:
Plaintiff
Party Name:
UNIVERSITY OF LOUISVILLE
Party Role:
Defendant

Court Case Summary

Filing Date:
2024-04-03
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Civil Rights Employment

Parties

Party Name:
POWE
Party Role:
Plaintiff
Party Name:
UNIVERSITY OF LOUISVILLE
Party Role:
Defendant

Court Case Summary

Filing Date:
2024-02-28
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Civil Rights Employment

Parties

Party Name:
WOLEK
Party Role:
Plaintiff
Party Name:
UNIVERSITY OF LOUISVILLE
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Contracts

Branch Contract Id Procurement Type Begin Date End Date Amount
Executive 2500001571 Special Authority Goods & Svcs 2024-09-23 2024-09-24 2333.6
Department CHFS - Office Of The Secretary
Category (915) COMMUNICATIONS AND MEDIA RELATED SERVICES
Authorization Conferences and Other Events Hosted by Agencies
Executive 2500000288 Special Authority Goods & Svcs 2024-07-22 2024-07-25 4200
Department CHFS - Office Of The Secretary
Category (915) COMMUNICATIONS AND MEDIA RELATED SERVICES
Authorization Conferences and Other Events Hosted by Agencies
Executive 2000000727 Memorandum of Agreement 2019-12-20 2020-02-28 5000
Department Board Of Nursing
Category (971) REAL PROPERTY RENTAL OR LEASE
Authorization Memorandum of Agreement
Document View Document

Government Spending

Branch Date of Service Fiscal Year Cabinet Department Classification Item Name Amount
Executive 2025-02-25 2025 Finance & Administration Cabinet Office Of The Controller Claims Claims 38717.71
Executive 2025-02-19 2025 Education and Labor Cabinet Department Of Education Fin Assist/Non-State Agencies Nutritional & Health Serv Asst 6051.84
Executive 2025-02-10 2025 Education and Labor Cabinet Department For Workforce Investment Fin Assist/Non-State Emp Rehab-Client Serv Cst-1099 Rpt 12500
Executive 2025-02-06 2025 Education and Labor Cabinet Department For Workforce Investment Fin Assist/Non-State Emp Rehab-Client Serv Cst-1099 Rpt 18022.25
Executive 2025-02-04 2025 Finance & Administration Cabinet Office Of The Controller Claims Claims 4150.32

Sources: Kentucky Secretary of State